Nu Skin Enterprises (NYSE:NUS) Cut to “Strong Sell” at Zacks Research

Nu Skin Enterprises (NYSE:NUSGet Free Report) was downgraded by equities research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a report issued on Monday,Zacks.com reports.

Several other equities research analysts also recently weighed in on NUS. Weiss Ratings reissued a “hold (c)” rating on shares of Nu Skin Enterprises in a research report on Thursday, January 22nd. Wall Street Zen lowered Nu Skin Enterprises from a “buy” rating to a “hold” rating in a report on Saturday, February 14th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Reduce”.

Get Our Latest Research Report on NUS

Nu Skin Enterprises Price Performance

NUS stock opened at $7.54 on Monday. The stock’s 50 day moving average is $9.90 and its two-hundred day moving average is $10.58. Nu Skin Enterprises has a 52-week low of $5.32 and a 52-week high of $14.62. The company has a market capitalization of $362.90 million, a PE ratio of 2.36 and a beta of 1.05. The company has a quick ratio of 1.40, a current ratio of 2.08 and a debt-to-equity ratio of 0.25.

Nu Skin Enterprises (NYSE:NUSGet Free Report) last released its earnings results on Thursday, February 12th. The company reported $0.29 EPS for the quarter, missing the consensus estimate of $0.30 by ($0.01). The business had revenue of $370.32 million for the quarter, compared to analysts’ expectations of $382.70 million. Nu Skin Enterprises had a net margin of 10.79% and a return on equity of 8.14%. Nu Skin Enterprises has set its FY 2026 guidance at 0.800-1.200 EPS and its Q1 2026 guidance at 0.100-0.200 EPS. Analysts predict that Nu Skin Enterprises will post 1.05 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Nu Skin Enterprises

Several institutional investors have recently made changes to their positions in NUS. Hillsdale Investment Management Inc. bought a new stake in shares of Nu Skin Enterprises in the 2nd quarter worth approximately $5,279,000. Portolan Capital Management LLC bought a new position in Nu Skin Enterprises during the 3rd quarter worth $7,274,000. Charles Schwab Investment Management Inc. increased its position in Nu Skin Enterprises by 22.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,621,785 shares of the company’s stock worth $25,222,000 after buying an additional 481,231 shares during the period. Prescott Group Capital Management L.L.C. lifted its stake in Nu Skin Enterprises by 24.4% in the second quarter. Prescott Group Capital Management L.L.C. now owns 1,734,608 shares of the company’s stock valued at $13,860,000 after buying an additional 340,000 shares during the last quarter. Finally, Prudential Financial Inc. boosted its holdings in shares of Nu Skin Enterprises by 104.2% during the second quarter. Prudential Financial Inc. now owns 601,697 shares of the company’s stock valued at $4,808,000 after acquiring an additional 307,085 shares during the period. 82.84% of the stock is owned by institutional investors.

About Nu Skin Enterprises

(Get Free Report)

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.

Further Reading

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.